Shenzhen Neptunus Interlong Bio-technique Company Limited (8329.HK) HKSE

Currency In HKD

AD

Valuation

Market Cap239.64M
Enterprise Value113.22M
P/E Ratio-2.62
PEG Ratio0.13
Price/Sales Ratio0.11
Price/Book Ratio0.2
Enterprise/Revenue0.01
Enterprise/EBITDA0.27

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin-0.04
Operating Margin-0.05
AD

Management Effectiveness

Return On Assets-0.05
Return On Equity-0.08

Income Statement

Revenue972.01M
Revenue/Share0.67
Gross Profit287.22M
EBITDA48.1M
Net Income-40.74M
Diluted EPS-0.02

Balance Sheet

Total Cash212.22M
Total Cash/Share0.13
Total Debt96.37M
Total Debt/Equity0.15
Current Ratio2
Book Value Per Share0.42

Price History

52-Week Change-39.19
52-Week High0.18
52-Week Low0.09
Moving Average 50 Days0.1
Moving Average 200 Days0.13

Statistics

Average Volume332,343
Shares Outstanding1.68B
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.09
Last Split FactorN/A
Last Split DateN/A
AD